SAVA

Cassava Sciences, Inc.

21.94 USD
+0.01 (+0.05%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Cassava Sciences, Inc. stock is down -10.74% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 41.67% of the previous 23 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 7 PUTs, 3 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
14 Feb 15:52 17 Jan, 2025 25.00 PUT 147 197
14 Feb 15:52 17 Jan, 2025 35.00 PUT 36 2
15 Feb 15:02 16 Jan, 2026 12.50 PUT 50 1489
16 Feb 20:56 16 Feb, 2024 20.00 CALL 100 203
20 Feb 15:22 16 Jan, 2026 35.00 CALL 40 1266
21 Feb 17:56 16 Jan, 2026 12.50 PUT 50 1611
21 Feb 17:56 16 Jan, 2026 12.50 PUT 50 1611
21 Feb 17:57 16 Jan, 2026 12.50 PUT 50 1611
21 Feb 18:07 16 Jan, 2026 12.50 PUT 96 1611
23 Feb 15:49 17 May, 2024 25.00 CALL 450 3272

About Cassava Sciences, Inc.

Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial.